Clinical Trials Browser

NCT06866951 2025-12-16

A Clinical Study Comparing Chemotherapy Combined With PD-1 Inhibitor Versus Concurrent Chemoradiotherapy in Cervical Cancer Patients With Positive Lymph Nodes After Surgery: A Multicenter Randomized Controlled Clinical Trial

Phase 2/3 Withdrawn

Gynecologic

Uterine Cervical Neoplasms

NCT01861938 2025-10-02

Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients

Phase 2/3 Withdrawn

Dermatologic

Melanoma, Neoplasm Metastasis

NCT02883361 2024-12-05

MI for AIs

Phase 2/3 Withdrawn

Breast

Breast Neoplasms, Medication Adherence

NCT04575064 2024-10-09

An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY

Phase 2/3 Withdrawn

Lymphoid

COVID-19, Lymphoma, Follicular

NCT05316064 2024-05-10

Reducing Abundance of Human Papilloma Virus in Women by Taking Probiotic

Phase 2/3 Withdrawn

Papillomavirus Infections

NCT03742596 2023-03-15

Effect of Probiotics Supplementation on the Side Effects of Radiation Therapy Among Colorectal Cancer Patients

Phase 2/3 Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT02548715 2022-07-13

LSHT

Phase 2/3 Withdrawn

Head & Neck

Hypothyroidism, Neoplasms, Postoperative Complications

NCT04795596 2022-04-15

Secondary Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancers

Phase 2/3 Withdrawn

Gynecologic

Ovarian Neoplasms

NCT03800784 2021-12-15

Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer

Phase 2/3 Withdrawn

Genitourinary

Prostatic Neoplasms

NCT02860494 2021-05-03

EVEROST

Phase 2/3 Withdrawn

Tuberous Sclerosis

NCT02272699 2021-03-18

Neoadjuvant Treatment of Nimotuzumab With Chemotherapy or Radiotherapy in Resectable Esophageal Squamous Cell Carcinoma

Phase 2/3 Withdrawn

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT00397761 2021-02-17

Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast Cancer

Phase 2/3 Withdrawn

Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT03342300 2020-05-19

PDVPSTS

Phase 2/3 Withdrawn

Sarcoma

NCT04105374 2020-03-24

Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma

Phase 2/3 Withdrawn

CNS

Astrocytoma, Glioblastoma, Oligodendroglioma

NCT04044651 2020-01-09

Lenvatinib Plus Nivolumab Versus Lenvatinib for Advanced Hepatocellular Carcinoma With Hepatitis B Virus Infection

Phase 2/3 Withdrawn

Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular

NCT02527772 2019-06-04

LD-FOX4/HCC

Phase 2/3 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular

NCT02534337 2019-06-04

Gemcitabine Plus Oxaliplatin Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma

Phase 2/3 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular

NCT02584556 2019-06-04

Adjuvant Transcatheter Arterial Chemoembolization Versus Adjuvant Systemic Chemotherapy for Hepatocellular Carcinoma

Phase 2/3 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular

NCT02585479 2019-06-04

Systemic Chemotherapy Versus Transcatheter Arterial Chemoembolization(TACE) for Hepatocellular Carcinoma

Phase 2/3 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular

NCT03346304 2019-02-01

PEARL

Phase 2/3 Withdrawn

Thoracic

Lung Neoplasms

NCT00894101 2018-07-20

Positron Emission Tomography Imaging With [F-18] FLT Compared to [F-18] FDG in Cancer Patients for Treatment Evaluation

Phase 2/3 Withdrawn

Head & Neck

Head and Neck Neoplasms

NCT01724242 2017-11-28

Vaginal DHEA for Women After Breast Cancer

Phase 2/3 Withdrawn

Breast

Breast Neoplasms, Orgasm, Urinary Incontinence

NCT01961934 2016-09-28

C11-Sodium Acetate PET/CT Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progression

Phase 2/3 Withdrawn

CNS

Glioblastoma, Glioma, Recurrence

NCT01389986 2016-08-30

Effects of Gum Chewing on Recovery of Bowel Function Following Abdominal Surgery for Endometrial and Ovarian Cancer

Phase 2/3 Withdrawn

Intestinal Pseudo-Obstruction

NCT01598584 2015-09-28

Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic Cancer

Phase 2/3 Withdrawn

Gastrointestinal

Pancreatic Neoplasms

NCT00922129 2014-01-14

Effectiveness of Conversion to Sirolimus Versus Calcineurin Inhibitor (CNI) Reduction in Renal Transplant Patients With Prostate Cancer

Phase 2/3 Withdrawn

Genitourinary

Prostatic Neoplasms

NCT01058317 2013-11-21

Propranolol Administration in Pediatric Patients With Recurrent Respiratory Papillomatosis

Phase 2/3 Withdrawn

Recurrent respiratory papillomatosis, Papilloma

NCT00027976 2013-08-05

Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses

Phase 2/3 Withdrawn

DermatologicOther neoplasm

Precancerous Conditions, Keratosis, Actinic

NCT00026468 2013-07-24

Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis

Phase 2/3 Withdrawn

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00851162 2012-11-28

Using Mesenchymal Stem Cells to Fill Bone Void Defects in Patients With Benign Bone Lesions

Phase 2/3 Withdrawn

Sarcoma

Bone Neoplasms

NCT00363441 2012-01-19

A Study of Conventional 3D Radiation vs. Intensity-Modulated Radiation in Squamous Cell Cancer of the Head and Neck

Phase 2/3 Withdrawn

Head & Neck

Head and Neck Neoplasms, Neoplasms, Squamous Cell